Atlas Trials

Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT

Clinical trial NCT03455972 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03455972
Sponsor
The First Affiliated Hospital of Soochow University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Safety and Efficacy
Start date
2018-02-20
Primary completion
2027-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.